# Saia Inc: financial statements, quarterly

SAIA · Nasdaq · CIK 1177702 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/saia.md) · [Financials](/companies/saia/financials.md) · [Filings](/companies/saia/filings.md) · [Insiders](/companies/saia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/saia/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [775](/filings/0000950170-24-117401.md) | [751 d](/filings/0001193125-26-067030.md) | [755](/filings/0000950170-25-059315.md) | [823](/filings/0000950170-25-098789.md) | [842](/filings/0001193125-25-258666.md) | [789 d](/filings/0001193125-26-067030.md) | [788](/filings/0001193125-26-197324.md) | [817](/filings/0001193125-26-326240.md) | [840](/filings/0001193125-25-258666.md) | [790 d](/filings/0001193125-26-067030.md) | [806](/filings/0001193125-26-197324.md) | [956](/filings/0001193125-26-326240.md) |
| Operating income | $m | [128](/filings/0000950170-24-117401.md) | [113 d](/filings/0001193125-26-067030.md) | [118](/filings/0000950170-25-059315.md) | [138](/filings/0000950170-25-098789.md) | [125](/filings/0001193125-25-258666.md) | [101 d](/filings/0001193125-26-067030.md) | [70.2](/filings/0001193125-26-197324.md) | [99.4](/filings/0001193125-26-326240.md) | [119](/filings/0001193125-25-258666.md) | [64.0 d](/filings/0001193125-26-067030.md) | [66.8](/filings/0001193125-26-197324.md) | [125](/filings/0001193125-26-326240.md) |
| Interest expense | $m | [0.5](/filings/0000950170-23-055988.md) | [0.9 d](/filings/0001193125-26-067030.md) | [0.5](/filings/0000950170-25-059315.md) | [2.4](/filings/0000950170-25-098789.md) | [3.0](/filings/0001193125-25-258666.md) | [3.0 d](/filings/0001193125-26-067030.md) | [4.3](/filings/0001193125-26-197324.md) | [4.7](/filings/0001193125-26-326240.md) | [4.5](/filings/0001193125-25-258666.md) | [2.9 d](/filings/0001193125-26-067030.md) | [2.6](/filings/0001193125-26-197324.md) | [2.0](/filings/0001193125-26-326240.md) |
| Income tax | $m | [32.0](/filings/0000950170-24-117401.md) | [26.4 d](/filings/0001193125-26-067030.md) | [28.2](/filings/0000950170-25-059315.md) | [33.1](/filings/0000950170-25-098789.md) | [29.9](/filings/0001193125-25-258666.md) | [22.7 d](/filings/0001193125-26-067030.md) | [15.8](/filings/0001193125-26-197324.md) | [24.2](/filings/0001193125-26-326240.md) | [28.5](/filings/0001193125-25-258666.md) | [13.9 d](/filings/0001193125-26-067030.md) | [15.2](/filings/0001193125-26-197324.md) | [31.2](/filings/0001193125-26-326240.md) |
| Net income | $m | [98.2](/filings/0000950170-24-117401.md) | [89.2 d](/filings/0001193125-26-067030.md) | [90.7](/filings/0001193125-25-258666.md) | [103](/filings/0001193125-25-258666.md) | [92.7](/filings/0001193125-25-258666.md) | [76.1 d](/filings/0001193125-26-067030.md) | [49.8](/filings/0001193125-26-326240.md) | [71.4](/filings/0001193125-26-326240.md) | [86.3](/filings/0001193125-25-258666.md) | [47.5 d](/filings/0001193125-26-067030.md) | [49.9](/filings/0001193125-26-326240.md) | [94.3](/filings/0001193125-26-326240.md) |
| Diluted EPS | $ per share | [3.67](/filings/0000950170-24-117401.md) | not reported | [3.38](/filings/0000950170-25-059315.md) | [3.83](/filings/0000950170-25-098789.md) | [3.46](/filings/0001193125-25-258666.md) | not reported | [1.86](/filings/0001193125-26-197324.md) | [2.67](/filings/0001193125-26-326240.md) | [3.22](/filings/0001193125-25-258666.md) | not reported | [1.86](/filings/0001193125-26-197324.md) | [3.51](/filings/0001193125-26-326240.md) |
| Basic EPS | $ per share | [3.69](/filings/0000950170-24-117401.md) | not reported | [3.40](/filings/0000950170-25-059315.md) | [3.84](/filings/0000950170-25-098789.md) | [3.47](/filings/0001193125-25-258666.md) | not reported | [1.86](/filings/0001193125-26-197324.md) | [2.67](/filings/0001193125-26-326240.md) | [3.23](/filings/0001193125-25-258666.md) | not reported | [1.86](/filings/0001193125-26-197324.md) | [3.52](/filings/0001193125-26-326240.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [249](/filings/0000950170-23-055988.md) | [296](/filings/0000950170-25-025702.md) | [12.3](/filings/0000950170-24-049188.md) | [11.2](/filings/0000950170-24-086878.md) | [14.4](/filings/0000950170-24-117401.md) | [19.5](/filings/0001193125-26-067030.md) | [16.5](/filings/0000950170-25-059315.md) | [18.8](/filings/0000950170-25-098789.md) | [35.5](/filings/0001193125-25-258666.md) | [19.7](/filings/0001193125-26-326240.md) | [39.2](/filings/0001193125-26-197324.md) | [84.0](/filings/0001193125-26-326240.md) |
| Current assets | $m | [646](/filings/0000950170-23-055988.md) | [649](/filings/0000950170-25-025702.md) | [416](/filings/0000950170-24-049188.md) | [446](/filings/0000950170-24-086878.md) | [437](/filings/0000950170-24-117401.md) | [436](/filings/0001193125-26-067030.md) | [470](/filings/0000950170-25-059315.md) | [451](/filings/0000950170-25-098789.md) | [497](/filings/0001193125-25-258666.md) | [435](/filings/0001193125-26-326240.md) | [499](/filings/0001193125-26-197324.md) | [588](/filings/0001193125-26-326240.md) |
| Total assets | $m | [2,485](/filings/0000950170-23-055988.md) | [2,584](/filings/0000950170-25-025702.md) | [2,766](/filings/0000950170-24-049188.md) | [2,957](/filings/0000950170-24-086878.md) | [3,082](/filings/0000950170-24-117401.md) | [3,167](/filings/0001193125-26-067030.md) | [3,365](/filings/0000950170-25-059315.md) | [3,458](/filings/0000950170-25-098789.md) | [3,501](/filings/0001193125-25-258666.md) | [3,483](/filings/0001193125-26-326240.md) | [3,564](/filings/0001193125-26-197324.md) | [3,725](/filings/0001193125-26-326240.md) |
| Current liabilities | $m | [299](/filings/0000950170-23-055988.md) | [322](/filings/0000950170-25-025702.md) | [338](/filings/0000950170-24-049188.md) | [328](/filings/0000950170-24-086878.md) | [347](/filings/0000950170-24-117401.md) | [278](/filings/0001193125-26-067030.md) | [328](/filings/0000950170-25-059315.md) | [303](/filings/0000950170-25-098789.md) | [296](/filings/0001193125-25-258666.md) | [265](/filings/0001193125-26-326240.md) | [328](/filings/0001193125-26-197324.md) | [371](/filings/0001193125-26-326240.md) |
| Long-term debt | $m | [0.0](/filings/0000950170-23-055988.md) | [0.0](/filings/0000950170-25-025702.md) | [72.0](/filings/0000950170-24-049188.md) | [167](/filings/0000950170-24-086878.md) | [183](/filings/0000950170-24-117401.md) | [194](/filings/0001193125-26-067030.md) | [291](/filings/0000950170-25-059315.md) | [307](/filings/0000950170-25-098789.md) | [218](/filings/0001193125-25-258666.md) | [163](/filings/0001193125-26-326240.md) | [112](/filings/0001193125-26-197324.md) | [100](/filings/0001193125-26-326240.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,849](/filings/0000950170-24-117401.md) | [1,941](/filings/0001193125-26-067030.md) | [2,029](/filings/0001193125-25-258666.md) | [2,136](/filings/0001193125-25-258666.md) | [2,231](/filings/0001193125-25-258666.md) | [2,311](/filings/0001193125-26-326240.md) | [2,360](/filings/0001193125-26-326240.md) | [2,437](/filings/0001193125-26-326240.md) | [2,526](/filings/0001193125-25-258666.md) | [2,578](/filings/0001193125-26-326240.md) | [2,626](/filings/0001193125-26-326240.md) | [2,727](/filings/0001193125-26-326240.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [125 d](/filings/0000950170-24-117401.md) | [162 d](/filings/0001193125-26-067030.md) | [106](/filings/0000950170-25-059315.md) | [131 d](/filings/0000950170-25-098789.md) | [182 d](/filings/0001193125-25-258666.md) | [165 d](/filings/0001193125-26-067030.md) | [109](/filings/0001193125-26-197324.md) | [171 d](/filings/0001193125-26-326240.md) | [178 d](/filings/0001193125-25-258666.md) | [137 d](/filings/0001193125-26-067030.md) | [140](/filings/0001193125-26-197324.md) | [152 d](/filings/0001193125-26-326240.md) |
| Capital expenditure | $m | [114 d](/filings/0000950170-24-117401.md) | [99.4 d](/filings/0001193125-26-067030.md) | [457](/filings/0000950170-25-059315.md) | [225 d](/filings/0000950170-25-098789.md) | [193 d](/filings/0001193125-25-258666.md) | [168 d](/filings/0001193125-26-067030.md) | [203](/filings/0001193125-26-197324.md) | [175 d](/filings/0001193125-26-326240.md) | [90.3 d](/filings/0001193125-25-258666.md) | [99.8 d](/filings/0001193125-26-067030.md) | [66.1](/filings/0001193125-26-197324.md) | [94.9 d](/filings/0001193125-26-326240.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.7](/filings/0000950170-23-055988.md) | [26.7](/filings/0000950170-24-049188.md) | [26.7](/filings/0000950170-24-086878.md) | [26.8](/filings/0000950170-24-117401.md) | [26.8](/filings/0000950170-25-059315.md) | [26.8](/filings/0000950170-25-098789.md) | [26.8](/filings/0001193125-25-258666.md) | [26.8](/filings/0001193125-26-197324.md) | [26.8](/filings/0001193125-26-326240.md) | [26.8](/filings/0001193125-25-258666.md) | [26.8](/filings/0001193125-26-197324.md) | [26.8](/filings/0001193125-26-326240.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,674,650 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-326240.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.